Gullik Håkan Wickholm
Director/Miembro de la Junta en Beactica Therapeutics AB .
Perfil
Gullik Håkan Wickholm is currently a Director at Beactica Therapeutics AB and GHW Consulting AB.
Previously, he served as the Chief Executive Officer at Lytix Biopharma AS from 2014 to 2017.
He also worked as the Head-Regional Business Development at AstraZeneca.
AS and as a Director at Genovis AB.
Wickholm received his undergraduate degree from the University of Uppsala.
Cargos activos de Gullik Håkan Wickholm
| Empresas | Cargo | Inicio |
|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Miembro de la Junta | 01/01/2018 |
| GHW Consulting AB | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Gullik Håkan Wickholm.
| Empresas | Cargo | Fin |
|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - |
| GENOVIS AB | Director/Miembro de la Junta | - |
| LYTIX BIOPHARMA | Director Ejecutivo | 07/09/2017 |
Formación de Gullik Håkan Wickholm.
| University of Uppsala | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| GENOVIS AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
- Bolsa de valores
- Insiders
- Gullik Håkan Wickholm
